Drug Profile
Bevacizumab biosimilar - Dr. Reddy's Laboratories
Alternative Names: DRL-BZ; Persivia; VersavoLatest Information Update: 21 Mar 2024
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Class Antineoplastics; Eye disorder therapies; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Angiogenesis inhibitors; Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Breast cancer; Cervical cancer; Colorectal cancer; Fallopian tube cancer; Glioblastoma; Non-small cell lung cancer; Ovarian cancer; Peritoneal cancer; Renal cell carcinoma